AI MARKET SCANNING

Abivax SA

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.21%
MAX GAP RECORD +5.94%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ABVX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Sep 21, 2026 Earnings Release 2026-09-21 (AFTER CLOSE (22:00))
-0.69%
May 22, 2026 Earnings Release 2026-05-22 (AFTER CLOSE)
+0.00%
Mar 23, 2026 Earnings Release 2026-03-23 (AFTER CLOSE)
+0.64%
Dec 15, 2025 Earnings Release 2025-12-15 (AFTER CLOSE)
-4.16%
Sep 08, 2025 Earnings Release 2025-09-08 (AFTER CLOSE)
-0.67%
Jun 03, 2025 Earnings Release 2025-06-03 (AFTER CLOSE)
+5.94%
Oct 20, 2023 Earnings Release 2023-10-20 (UNDETERMINED)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.4%
Bullish Gaps (1)
Bearish Gaps (1)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ABVX

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-09-09 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 192m +6.69%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗